Journals / Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2003 / Cilt: 14 - Sayı: 2

Alterations in haemostatic parameters in patients with chronic renal failure on regular hemodialysis treatment

Düzenli hemodiyaliz tedavisi gören kronik renal yetmezlikli olgularda hemostatik parametrelerdeki değişmeler

Pages
74–80
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Because of AT HI and D-dimer don't change with one hemodialysis session we concluded that AT III and D-dimer might be used to observe the activations of coagulation and fibrinolytic system in the patients with CRF on long-term hemodialysis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In order to investigate the changes of haemostatic parameters and the effects of regular hemodialysis in the patients with chronic renal failure (CRF) we studied in 20 healthy controls and in 20 patients with CRF undergoing regular hemodialysis with cuprophan (CP) membrane.
📊
Key Findings & Data:Decrease of AT in activity and increase of fibrinogen concentration in the patients with CRF undergoing regular hemodialysis treatment that we established in this study showed the developing of hypercoagulation in this cases, and increase of FDP-D-dimer concentrations showed the activation of fibrinolytic system secondary of hypercoagulation.
💡
Conclusion & Impact:Because of AT HI and D-dimer don't change with one hemodialysis session we concluded that AT III and D-dimer might be used to observe the activations of coagulation and fibrinolytic system in the patients with CRF on long-term hemodialysis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In order to investigate the changes of haemostatic parameters and the effects of regular hemodialysis in the patients with chronic renal failure (CRF) we studied in 20 healthy controls and in 20 patients with CRF undergoing regular hemodialysis with cuprophan (CP) membrane. To show the effects of hemodialysis we investigated blood samples of working group before and after hemodialysis. In all groups we determined AT IH, D-dimer, platelets, fibrinogen, FDP, PT, PTT and routine parameters. In working group before dialysis platelets were lower than controls and fibrinogen levels were higher and AT ni levels were lower and D-dimer levels were higher and PT was longer, PTT was found in the normal ranges in each group. There were no established differences between haemostatic parameters before and after dialysis. Decrease of AT in activity and increase of fibrinogen concentration in the patients with CRF undergoing regular hemodialysis treatment that we established in this study showed the developing of hypercoagulation in this cases, and increase of FDP-D-dimer concentrations showed the activation of fibrinolytic system secondary of hypercoagulation. Because of AT HI and D-dimer don't change with one hemodialysis session we concluded that AT III and D-dimer might be used to observe the activations of coagulation and fibrinolytic system in the patients with CRF on long-term hemodialysis.

Özet

Düzenli hemodiyaliz tedavisi gören kronik renal yetmezlikli (KRY) hastalarda, hemostatik parametrelerdeki değişimleri ve hemodiyaliz tedavisinin bu parametreler üzerindeki etkilerini incelemek amacıyla, 20 sağlıklı olguda ve kuprofan (CP) membranlanyla düzenli hemodiyaliz tedavisi gören 20 KRY'li olguda çalışılmıştır. Hemodiyaliz tedavisinin etkilerinin gösterilebilmesi amacıyla da, çalışma grubundaki hastalar hemodiyaliz seansı öncesi ve sonrasında kan örnekleri alınarak incelenmiştir. Tüm gruplarda trombosit sayısı, protrombin zamanı (PT), parsiyel tromboplastin zamanı (PTT), fıbrinojen, fibrin-fibrinojen yıkım ürünleri (FDP), antitrombin HI (AT ÜT), D-dimer düzeyleri ve rutin parametreler tayin edilmiştir. Sağlıklı kontrol grubu ile diyaliz öncesindeki çalışma grubu karşılaştırıldığında, KRY'li grupta trombosit sayısı kontrol grubuna göre anlamlı azalmış, PT anlamlı uzamış, fibrinojen düzeyleri anlamlı artmış, AT IH aktivitesi anlamlı azalmış, D-Dimer düzeyleri kontrol grubuna göre anlamlı artmış olarak saptanmıştır. PTT her iki grupta da normal sınırlarda bulunmuştur. Diyaliz öncesi ve sonrasındaki değerler incelendiğinde, hemodiyaliz sonrasında hemostatik parametrelerde anlamlı fark saptanmamıştır. Bu çalışmada saptadığımız AT IH aktivitesindefci azalma ve fibrinojen konsantrasyonlanndaki artma bu olgularda hiperkoagülasyon geliştiğini veFDP-D-Dimer konsantrasyonlanndaki artış ise hiperkoagülasyona sekonder olarak fibrinolitik sistemin aktive olduğunu ortaya koymuştur. AT HI ve D-Dimer bir hemodiyaliz seansı ile değişmediğinden, bu parametrelerin uzun süreli hemodiyaliz tedavisi gören KRY'li hastalarda koagülasyon ve fibrinolitik sistemlerin aktivasyonlannın izlenmesinde kullanılabileceği kanısına varılmıştır.

🔖

Cite This Article

TÜRKALP, I., ÖZKAZANÇ, D., KARABULUT, A. (2022). Alterations in haemostatic parameters in patients with chronic renal failure on regular hemodialysis treatment. Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 14 - Sayı: 2, 74–80. https://ajindex.com/articles/571541

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Knudsen F, Sornesen PJ, Nilesen AH, Dyerberg J. Inhibitors of coagulation in terminal renal failure and during hemodialysis. Nephron 1988; 49: 335-6
  2. Vaziri ND, Gonzales EC, Wang J, Said S. Blood coagulation, fibrinolitic and inhibitory proteins in end-stage renal disease: Effect of hemodialysis. American J Kidney Dis 1998; 123(6):828-35
  3. Sagripanti A, Cupisti A, Baicchi U, Ferdeghini M, Morelli E, Barsotti G. Plasma parameters of prothrombotic state in chronic uremia. Nephron 1993; 63: 273-8
  4. Lai KN, Yin JA, Yuen PMP, Li PKT. Protein C, Protein S and Antithrombin III levels in patients on continuous ambulatory peritonial dialysis and hemodialysis. Nephron 1990; 56: 271-6
  5. Shibata T, Magari Y, Kamberi P, Ishu T. Significance of urinary fibrin/fibrinogen degredation products (FDP) D-Dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-DE72) in various renal diseases. Clin Nephrology 1995; 44(2): 91-5
  6. Gaffney PJ, Edgell T, Creighton-Kempsford LJ, Wheeler S and Tarelli E. Fibrin degradation product (FnDP) assays: Analysis of standardization issues and target antigens in plasma. Br J Haemotology 1995; 90: 187-94
  7. Selçuk YN, Tonbul Z, şanlı A. Diyaliz uygulanmayan üremik hastalarda trombosit fonksiyonları üreminin derecesine bağlı olarak değişiyor mu? Türk Hematoloji Onkoloji Dergisi 1996;6(1): 42-8
  8. Turney JH, Woods HF, Fewell MR, Weston MJ. Factor VIII complex in uremia and effects of haemodialysis. Br Med J 1981;282: 1653-5
  9. Knudsen F, Dyerberg J. Platelets and antithrombin III in uremia: The acute effect of haemodialysis. Scand J Clin Lab Invest 1985; 45: 341-7
  10. George CRP, Slichter SJ, Quadracci LJ, Striker GE, Harker LA. A kinetic evaluation of hemostasis in renal disease. N Eng J Med 1974; 291: 111-5
  11. Schmitt WG, Moake JL, Rudy CK, Vicks SL, Hamburger RJ. Alterations in hemostatic parameters during hemodialysis with dialysers of different membrane composition and flow design. The American J Med 1987; 83: 411-8
  12. Tomura S, Nkamura Y, Deguchi F, Ando R, Chida Y, Marumo F. Coagulation and fibrinolysis in patients with chronic renal failure undergoing conservative treatment. Thromb Res 1991;64(1): 81-90
  13. Sultan Y, London GM, Goldfarb B, Toulon P, Marchais SJ. Activation of platelets, coagulation and fibrinolysis in patients on long term hemodialysis: Influence of cuprophan and polyacrilonitrile membranes. Nephrol Dial Transplant 1990;5(5): 362-8
  14. Baumann H, Onarato V, Gauldie J, Ja